Skip to content

    Platinum Industries Q1 FY27 earnings call

    PLATIND
    Chemicals·11 Aug 2026
    Management Summary

    Platinum Industries Limited reported a challenging Q1 FY27 with consolidated revenue and profitability declines, attributed to a transition phase, capacity ramp-up, and product mix shifts. Despite the short-term headwinds, the company remains focused on strategic capacity expansion, with the Palghar facility now operational and the Egypt facility on track for commercial production by year-end. Management reiterated its 30-40% revenue growth guidance for FY27, driven by new capacities and a shift towards higher-value products, while acknowledging current margin pressures.

    Highlights

    5
    • Expanded Palghar facility commenced commercial production from May 21, 2026, adding ~60,000 tonnes per annum capacity.

    • Egypt facility progressing towards commercial production by December 31, 2026, with a planned capacity of 60,000 tonnes per annum.

    • Maintaining revenue growth guidance of 30-40% for FY27, with a 3-year CAGR target of 35%.

    • Oleo Chemicals segment generated INR 5.3 crores in Q1 FY27, targeting INR 55-60 crores by year-end and INR 150-200 crores in a 3-year horizon.

    • Strategic focus on higher-value products, capacity expansion, and increasing presence in domestic and international markets.

    Concerns

    6
    • Consolidated revenue from operations declined to INR 108.9 crores in Q1 FY27 from INR 115.4 crores in Q1 FY26.

    • Consolidated EBITDA decreased to INR 13.44 crores (Q1 FY27) from INR 15.16 crores (Q1 FY26), with EBITDA margin contracting to 12.34% from 13.14%.

    • PAT declined to INR 11.13 crores (Q1 FY27) from INR 13.07 crores (Q1 FY26).

    • Profitability impacted by ongoing transition, ramp-up phase, and less offtake of high-margin lead-free PVC products.

    • CPVC segment margins currently at 18%, with a target of 20-21% by Q4, impacted by demand-supply gap and raw material issues.

    • Commercial production for stearates (metallic soap plant) delayed to September/October 2026 from August.

    Key financials

    Single quarter

    07 metrics
    1. 01Consolidated Revenue from Operations₹108.9 Cr-5.6%YoY
    2. 02Consolidated EBITDA₹13.44 Cr-11.3%YoY
    3. 03Consolidated EBITDA Margin12.3%
    4. 04Consolidated PAT₹11.13 Cr-14.8%YoY
    5. 05Consolidated Basic & Diluted EPS₹2.03

    Segment breakdown

    Oleo Chemicals
    ₹5.3 Cr Revenue
    List

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Capex

    ₹15 crores

    Guidance & targets

    12
    CategoryTargetPriority
    Revenue
    Revenue Growth
    30-40%
    High
    Revenue
    Oleo Segment Revenue
    INR 55-60 crores
    High
    Revenue
    Oleo Segment Revenue
    INR 150-200 crores
    High
    Revenue
    Egypt Facility Revenue
    INR 30-35 crores
    High
    Revenue
    Egypt Facility Revenue
    INR 250-300 crores
    High
    Revenue
    Palghar Facility Revenue
    INR 700-800 crores
    High
    Profitability
    CPVC Segment Margins
    20-21%
    Medium
    Profitability
    PAT Margin
    11-12%
    High
    Profitability
    EBITDA Margin
    13-15%
    High
    Growth
    Overall CAGR Growth
    35%
    High
    Capacity
    Egypt Facility Commercial Production
    Before Dec 31, 2026
    High
    Capacity
    Stearates Commercial Production
    September/October 2026
    High

    What to watch in Q2 FY27

    5

    Palghar facility capacity utilization

    next quarter
    CurrentAround 30-35% expected in Q2, Q3
    TargetIncrease in utilization levels

    Why it matters

    Higher utilization of new capacity is crucial for improving operating leverage and overall profitability.

    So generally, it is as of now, around 30% to 35% we are expecting in Q2, Q3.

    Risks & concerns

    4
    RiskSeverity

    Moderation in profitability due to transition and ramp-up

    Consolidated top line and profitability impacted by ongoing transition and ramp-up phase of expanded manufacturing facility and less high-margin products.Management acknowledged

    medium

    CPVC segment margin pressure

    Current CPVC margins at 18% due to demand-supply gap and raw material sourcing issues, targeting 20-21% by Q4.Management acknowledged

    medium

    Impact of global events on supply chain and costs

    War scenario and shipping costs are preventing full pass-through of increased freight costs, impacting contribution margins.Management acknowledged

    medium

    Delay in metallic soap plant commissioning

    Commercial production for stearates (metallic soap plant) delayed from August to September/October 2026 due to equipment delay.Both acknowledged

    low

    Q&A highlights

    8

    “So, the demand has just picked up from August, and we see that from August until December, there's going to be a good demand for pipe sector because right now the PVC prices have been stabilized. It started going upwards.”

    Provides insight into the demand recovery for a key end-user industry after a period of degrowth.

    asked by Arnav Sakhuja

    3 min read5 chapters

    Detailed Narrative

    01

    Q1 FY27 Performance Overview and Challenges

    Platinum Industries reported a challenging Q1 FY27, with consolidated revenue from operations declining to INR 108.9 crores from INR 115.4 crores in Q1 FY26. Consolidated EBITDA also saw a reduction to INR 13.44 crores from INR 15.16 crores, leading to a margin contraction to 12.34% from 13.14%. Profit after tax stood at INR 11.13 crores, down from INR 13.07 crores in the prior year. Management attributed this moderation in profitability to an ongoing transition phase, capacity ramp-up, and a product mix shift towards less high-margin lead-free PVC products.

    02

    Capacity Expansion and Commercialization in Palghar

    A key milestone for the quarter was the commissioning of the expanded Palghar facility. Partial commercial operations for the CPVC facility (12,000 tonnes per annum) began in August 2025, with the remaining capacity of 48,000 tonnes per annum for PVC, CPVC, lubricants, and other products commencing commercial production from May 21, 2026. This expansion adds approximately 60,000 tonnes per annum of capacity, including 24,000 tonnes of lead-free PVC, 24,000 tonnes of CPVC, and 12,000 tonnes of lubricants. The total capacity in India is expected to reach 85,000 tonnes per annum, with the stearates capacity of 6,000 tonnes per annum now expected to commence commercial production in September/October 2026, a slight delay from the initial August target.

    03

    Strategic Importance of Egypt Facility

    The company is making significant progress on its manufacturing facility in Egypt, with a commitment to commence commercial production before December 31, 2026. This facility involves a total investment of approximately INR 68 crores and will have a production capacity of 60,000 tonnes per annum. Egypt is strategically important as it provides access to attractive international markets, including duty-free access to the United States through Qualified Industrial Zones and free trade access to key South American markets. Management expects the Egypt facility to contribute INR 30-35 crores in revenue for FY27, revised down from an initial estimate of INR 50-60 crores, and projects INR 250-300 crores over a three-year period.

    04

    Product Mix and Margin Dynamics

    The shift in product mix has impacted margins. While lead-free additives previously commanded higher margins (contributing to 23% margins in FY23-24), the newer CPVC additives started with lower contribution margins of 3-7% during their initial phase. Currently, CPVC segment margins are around 18%, with a target to reach 20-21% by Q4, contingent on improved supply chain and demand. Overall PAT margin is expected to be maintained at 11-12% in the coming months, and EBITDA margin is guided to be 13-15% going forward. The company noted that current raw material sourcing challenges and increased shipping costs due to global events are temporarily impacting their ability to fully pass on costs, affecting contribution margins.

    05

    Oleo Chemicals and New Business Initiatives

    The Oleo Chemicals segment generated INR 5.3 crores in revenue during Q1 FY27. The company is positive about this segment, targeting INR 55-60 crores by the end of FY27 and INR 150-200 crores over a three-year horizon. Platinum Industries is currently engaged in seed marketing for Oleo Chemicals in India and has exported to Malaysia and Turkey. The long-term plan involves establishing manufacturing capabilities for these products within one and a half years. The company is also exploring the Rivadu Lifesciences (pharma) business, currently identifying its business model and negotiating collaborations, with some revenue already being generated.

    This is an AI-generated summary of a publicly available earnings call transcript.